Company Filing History:
Years Active: 2020
Title: The Innovations of Liangbin Xiong
Introduction
Liangbin Xiong is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of genetically-engineered organisms for pharmaceutical applications. His work focuses on enhancing the production efficiency and quality of steroidal compounds.
Latest Patents
Liangbin Xiong holds 1 patent for his invention titled "Genetically-engineered mycobacterium strain and a use thereof in the preparation of steroidal compounds." This invention relates to a genetically-engineered strain that lacks acyl-CoA dehydrogenase genes fadE31, fadE32, and fadE33. The strain is designed to improve the production of steroidal compounds by enriching the types of valuable intermediates, enhancing production efficiency, and reducing energy consumption and costs in steroid drug production.
Career Highlights
Liangbin Xiong is affiliated with the East China University of Science and Technology, where he conducts research and develops innovative solutions in biotechnology. His work has been instrumental in advancing the field and has garnered attention for its practical applications in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Fengqing Wang and Liqin Xu, who have collaborated with him on various research projects. Their combined expertise contributes to the success of their innovative endeavors.
Conclusion
Liangbin Xiong's contributions to biotechnology through his patented inventions demonstrate his commitment to advancing pharmaceutical production methods. His work not only enhances efficiency but also paves the way for future innovations in the field.